These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9368477)

  • 1. Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia.
    Kahl C; Florschütz A; Müller G; Jentsch-Ullrich K; Arland M; Leuner S; Franke A; Höffkes HG
    Ann Hematol; 1997 Sep; 75(3):91-4. PubMed ID: 9368477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.
    Gahn B; Haase D; Unterhalt M; Drescher M; Schoch C; Fonatsch C; Terstappen LW; Hiddemann W; Büchner T; Bennett JM; Wörmann B
    Leukemia; 1996 Jun; 10(6):946-51. PubMed ID: 8667650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival.
    Goasguen JE; Matsuo T; Cox C; Bennett JM
    Leukemia; 1992 Jun; 6(6):520-5. PubMed ID: 1318461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes.
    Kuriyama K; Miyazaki Y; Arimura K; Nagai K; Nakamura H; Matsuo T; Tomonaga M
    Leuk Res; 1995 Feb; 19(2):121-5. PubMed ID: 7869740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.
    Lima CS; Vassalo J; Lorand-Metze I; Bechelli AP; Souza CA
    Haematologia (Budap); 1997; 28(2):85-95. PubMed ID: 9283908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.
    Estienne MH; Fenaux P; Preudhomme C; Lai JL; Zandecki M; Lepelley P; Cosson A
    Clin Lab Haematol; 1990; 12(1):57-65. PubMed ID: 2344717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG.
    Haferlach T; Bennett JM; Löffler H; Gassmann W; Andersen JW; Tuzuner N; Casslleth PA; Fonatsch C; Schoch C; Schlegelberger B; Becher R; Thiel E; Ludwig WD; Sauerland MC; Heinecke A; Büchner T
    Leuk Lymphoma; 1996 Oct; 23(3-4):227-34. PubMed ID: 9031103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
    Kuriyama K; Tomonaga M; Matsuo T; Kobayashi T; Miwa H; Shirakawa S; Tanimoto M; Adachi K; Emi N; Hiraoka A
    Br J Haematol; 1994 Apr; 86(4):767-73. PubMed ID: 7918070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
    Hirst WJ; Mufti GJ
    Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis.
    Tamura S; Takemoto Y; Wada H; Itoh T; Mori A; Saheki K; Okada M; Takatsuka H; Fujimori Y; Okamoto T; Kakishita E
    Br J Haematol; 1998 Jun; 101(4):743-8. PubMed ID: 9674749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation.
    Brito-Babapulle F; Catovsky D; Galton DA
    Br J Haematol; 1988 Apr; 68(4):411-5. PubMed ID: 3163932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia.
    Brito-Babapulle F; Catovsky D; Galton DA
    Br J Haematol; 1987 Aug; 66(4):445-50. PubMed ID: 3478074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.
    Rozman M; Navarro JT; Arenillas L; Aventín A; Giménez T; Alonso E; Perea G; Camós M; Navarrete M; Tuset E; Florensa L; Millá F; Nomdedéu J; de la Banda E; Díaz-Beyá M; Pratcorona M; Garrido A; Navarro B; Brunet S; Sierra J; Esteve J;
    Ann Hematol; 2014 Oct; 93(10):1695-703. PubMed ID: 24824767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical importance of morphological multilineage dysplasia in acute myeloid leukemia with myelodysplasia related changes].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ
    Korean J Lab Med; 2010 Jun; 30(3):231-8. PubMed ID: 20603581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and poor outcomes in patients with de novo AML with trilineage myelodysplasia].
    Arimura K; Kuriyama K; Miyazaki Y; Nagai K; Fukushima T; Yoshida S; Moriuchi Y; Momita S; Tomonaga M
    Rinsho Ketsueki; 1995 Feb; 36(2):98-105. PubMed ID: 7715091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.
    Meckenstock G; Aul C; Hildebrandt B; Heyll A; Germing U; Wehmeier A; Giagounidis A; Suedhoff T; Burk M; Soehngen D; Schneider W
    Leuk Lymphoma; 1998 May; 29(5-6):523-31. PubMed ID: 9643566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.